The latest price target for Equifax (NYSE:EFX) was reported by Barclays on February 7, 2025. The analyst firm set a price target for $325.00 expecting EFX to rise to within 12 months (a possible 36.54% upside). 43 analyst firms have reported ratings in the last year.

The latest analyst rating for Equifax (NYSE:EFX) was provided by Barclays, and Equifax maintained their overweight rating.

The last upgrade for Equifax Inc happened on December 16, 2024 when Exane BNP Paribas raised their price target to $305. Exane BNP Paribas previously had a neutral for Equifax Inc.

The last downgrade for Equifax Inc happened on December 12, 2024 when Wolfe Research changed their price target from N/A to N/A for Equifax Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Equifax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Equifax was filed on February 7, 2025 so you should expect the next rating to be made available sometime around February 7, 2026.

While ratings are subjective and will change, the latest Equifax (EFX) rating was a maintained with a price target of $335.00 to $325.00. The current price Equifax (EFX) is trading at is $238.03, which is out of the analyst’s predicted range.